English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Zynex
Patient Daily
| May 18, 2023
Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
Patient Daily
| May 18, 2023
Zynex Announces Proposed Secondary Public Offering of Common Stock
Patient Daily
| May 18, 2023
Zynex Announces Update Regarding Previously Announced Offerings
Patient Daily
| May 18, 2023
Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering
Patient Daily
| Apr 24, 2023
Zynex, Inc. to Announce First Quarter 2023 Financial Results
Trending
+
Technology/Innovation
Patient Daily
| May 8, 2025
Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+
Technology/Innovation
Patient Daily
| May 7, 2025
OTO Forum 2025 highlights innovation in ENT
+
Pharmaceuticals
Patient Daily
| May 8, 2025
Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+
Pharmaceuticals
Patient Daily
| May 8, 2025
National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments
